New hope for tough bladder cancers: drug tested after standard therapies fail
Disease control
Completed
This study tested a drug called enfortumab vedotin in Chinese patients with advanced bladder cancer that had spread and stopped responding to standard chemotherapy and immunotherapy. The main goal was to see if the drug could shrink tumors and for how long. Researchers also close…
Phase: PHASE2 • Sponsor: Astellas Pharma China, Inc. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC